Downloadable Slides

Share

Program Content

Activities

  • Individualizing 1L CLL Therapy
    Individualizing CLL Therapy: Frontline Treatment
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 30, 2024

    Expires: August 29, 2025

  • Individualizing 2L+ CLL Therapy
    Individualizing CLL Therapy: Second-Line Treatment and Beyond
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 13, 2024

    Expires: September 12, 2025

Faculty

cover img faculity

Jeremy S. Abramson, MD, MMSc

Director, Center for Lymphoma
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Farrukh T. Awan, MD, MS, MBA

Associate Director, Section of Hematologic Malignancies/Transplantation and Cellular Therapy
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AbbVie Inc.; AstraZeneca; Beigene, Ltd.; and Bristol Myers Squibb.

AbbVie Inc.

AstraZeneca

BeiGene, Ltd.

Bristol Myers Squibb

Partners

CLL Society

ProCE Banner